Biotech-Übernahme-Hammer beflügelt Morphosys

Morphosys-Aktien haben es am Montagmittag gleich über drei gleitende Trendlinien geschafft: Den 21-Tage, 50-Tage- und 200-Tage …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
604